Catheter Precision, Inc.
VTAK- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716621
No open-market purchases or sales by Catheter Precision, Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $57.2K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Catheter Precision, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +4 vs. Q2 2021
- Shares held
- 479.5K
- +32.9K (+7.4%) vs. Q2 2021
- Total value
- $1.50M
- −$446.0K (−22.9%) vs. Q2 2021
- New holders
- 8
- 5 more added
- Sold out
- 4
- 3 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTAK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 10 | $57.2K |
| Q1 2026 | 12 | $102.9K |
| Q4 2025 | 9 | $125.2K |
| Q3 2025 | 3 | $58 |
| Q2 2025 | 12 | $120.2K |
| Q1 2025 | 10 | $202.3K |
| Q4 2024 | 8 | $216.7K |
| Q3 2024 | 11 | $62.8K |
| Q2 2024 | 14 | $414.5K |
| Q1 2024 | 13 | $389.4K |
| Q4 2023 | 13 | $176.5K |
| Q3 2023 | 14 | $240.8K |
| Q2 2023 | 14 | $382.8K |
| Q1 2023 | 11 | $904.4K |
| Q4 2022 | 12 | $469.9K |
| Q3 2022 | 21 | $292.2K |
| Q2 2022 | 23 | $256.5K |
| Q1 2022 | 26 | $420.0K |
| Q4 2021 | 23 | $1.04M |
| Q3 2021 | 19 | $1.50M |
| Q2 2021 | 15 | $1.95M |
| Q1 2021 | 20 | $3.84M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Catheter Precision, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 149,887 | $471.0K | 0.00% | +4,726+3.3% | Added |
| Dowling & Yahnke LLC | 68,448 | $215.0K | 0.01% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 52,400 | $165.0K | 0.02% | −36,701−41.2% | Reduced |
| Geode Capital Management, LLC | 41,797 | $131.0K | 0.00% | +26,967+181.8% | Added |
| Susquehanna Fundamental Investments, LLC | 35,700 | $112.0K | 0.00% | +35,700 | New |
| Bank of New York Mellon Corp | 26,910 | $84.0K | 0.00% | +26,910 | New |
| Citadel Advisors LLC | 21,377 | $67.0K | 0.00% | +21,377 | New |
| Bank of America Corp | 16,055 | $50.0K | 0.00% | +85+0.5% | Added |
| Jane Street Group, LLC | 13,881 | $44.0K | 0.00% | +13,881 | New |
| Virtu Financial LLC | 13,106 | $41.0K | 0.00% | −48,445−78.7% | Reduced |
| Alethea Capital Management, LLC | 12,320 | $39.0K | 0.03% | 00.0% | Unchanged |
| State Street Corp | 10,300 | $32.0K | 0.00% | 00.0% | Unchanged |
| Avantax Planning Partners, Inc. | 10,000 | $31.0K | 0.00% | +10,000 | New |
| Morgan Stanley | 3,000 | $9.00K | 0.00% | +2,465+460.7% | Added |
| UBS Group AG | 2,672 | $8.00K | 0.00% | +2,672 | New |
| Tower Research Capital LLC (TRC) | 1,184 | $4.00K | 0.00% | +1,184 | New |
| Advisor Group Holdings, Inc. | 336 | $2.00K | 0.00% | −503−60.0% | Reduced |
| Wells Fargo & Company | 39 | $0 | 0.00% | +21+116.7% | Added |
| Key Financial Inc | 110 | $0 | 0.00% | +110 | New |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −16,822−100.0% | Sold out |
| MANA Advisors LLC | 0 | $0 | 0.00% | −10,334−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −157−100.0% | Sold out |
| CVA Family Office, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |